These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 22024001

  • 1. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
    Froehlich TE, Epstein JN, Nick TG, Melguizo Castro MS, Stein MA, Brinkman WB, Graham AJ, Langberg JM, Kahn RS.
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
    [Abstract] [Full Text] [Related]

  • 2. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder.
    McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Hellemann G, Sugar CA.
    J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1155-64. PubMed ID: 19858760
    [Abstract] [Full Text] [Related]

  • 3. DRD4 exon 3 genotype and ADHD: Randomised pharmacodynamic investigation of treatment response to methylphenidate.
    Naumova D, Grizenko N, Sengupta SM, Joober R.
    World J Biol Psychiatry; 2019 Jul; 20(6):486-495. PubMed ID: 29182037
    [Abstract] [Full Text] [Related]

  • 4. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
    Leddy JJ, Waxmonsky JG, Salis RJ, Paluch RA, Gnagy EM, Mahaney P, Erbe R, Pelham WE, Epstein LH.
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
    [Abstract] [Full Text] [Related]

  • 5. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
    Kereszturi E, Tarnok Z, Bognar E, Lakatos K, Farkas L, Gadoros J, Sasvari-Szekely M, Nemoda Z.
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec 05; 147B(8):1431-5. PubMed ID: 18214865
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: is there an interaction?
    Hong SB, Kim JW, Cho SC, Shin MS, Kim BN, Yoo HJ.
    J Child Adolesc Psychopharmacol; 2012 Oct 05; 22(5):343-52. PubMed ID: 23083021
    [Abstract] [Full Text] [Related]

  • 7. Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children.
    Cheon KA, Kim BN, Cho SC.
    Neuropsychopharmacology; 2007 Jun 05; 32(6):1377-83. PubMed ID: 17077808
    [Abstract] [Full Text] [Related]

  • 8. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
    Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK, Franke B.
    Am J Med Genet B Neuropsychiatr Genet; 2008 Mar 05; 147B(2):201-8. PubMed ID: 17955457
    [Abstract] [Full Text] [Related]

  • 9. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.
    Hamarman S, Fossella J, Ulger C, Brimacombe M, Dermody J.
    J Child Adolesc Psychopharmacol; 2004 Mar 05; 14(4):564-74. PubMed ID: 15662148
    [Abstract] [Full Text] [Related]

  • 10. Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.
    Froehlich TE, McGough JJ, Stein MA.
    CNS Drugs; 2010 Feb 05; 24(2):99-117. PubMed ID: 20088618
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA, Hawi Z, Kirley A, Fitzgerald M, Gill M, Robertson IH.
    Neuropsychopharmacology; 2005 Dec 05; 30(12):2290-7. PubMed ID: 16123773
    [Abstract] [Full Text] [Related]

  • 13. Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.
    Myer NM, Boland JR, Faraone SV.
    Mol Psychiatry; 2018 Sep 05; 23(9):1929-1936. PubMed ID: 29230023
    [Abstract] [Full Text] [Related]

  • 14. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.
    Kim BN, Kim JW, Cummins TD, Bellgrove MA, Hawi Z, Hong SB, Yang YH, Kim HJ, Shin MS, Cho SC, Kim JH, Son JW, Shin YM, Chung US, Han DH.
    J Clin Psychopharmacol; 2013 Jun 05; 33(3):356-62. PubMed ID: 23609393
    [Abstract] [Full Text] [Related]

  • 15. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
    Pasini A, Sinibaldi L, Paloscia C, Douzgou S, Pitzianti MB, Romeo E, Curatolo P, Pizzuti A.
    Eur J Paediatr Neurol; 2013 Jul 05; 17(4):407-14. PubMed ID: 23541676
    [Abstract] [Full Text] [Related]

  • 16. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.
    Joober R, Grizenko N, Sengupta S, Amor LB, Schmitz N, Schwartz G, Karama S, Lageix P, Fathalli F, Torkaman-Zehi A, Ter Stepanian M.
    Neuropsychopharmacology; 2007 Jun 05; 32(6):1370-6. PubMed ID: 17063150
    [Abstract] [Full Text] [Related]

  • 17. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.
    Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH, Stein MA.
    J Child Adolesc Psychopharmacol; 2009 Jun 05; 19(3):233-9. PubMed ID: 19519258
    [Abstract] [Full Text] [Related]

  • 18. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM, Roman T, Hutz MH, Genro JP, Shih MC, Hoexter MQ, Júnior N, Pechansky F, Bressan RA, Rohde LA.
    Synapse; 2011 Feb 05; 65(2):154-9. PubMed ID: 20593420
    [Abstract] [Full Text] [Related]

  • 19. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C, Faraone SV, Scassellati C.
    Mol Psychiatry; 2016 Jul 05; 21(7):872-84. PubMed ID: 27217152
    [Abstract] [Full Text] [Related]

  • 20. Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.
    Park S, Kim JW, Kim BN, Shin MS, Yoo HJ, Cho SC.
    J Psychopharmacol; 2014 Jul 05; 28(7):671-6. PubMed ID: 24763183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.